MKP-1 signaling events are required for early osteoclastogenesis in lineage defined progenitor populations by disrupting RANKL-induced NFATc1 nuclear translocation
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P30GM103331)
- National Institutes of Health (R01DE018290)
- National Institutes of Health (T32DE017551)
This publication has 38 references indexed in Scilit:
- Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and diseaseLife Sciences, 2012
- MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1Cytokine, 2011
- TGF-β Inducible Early Gene 1 Regulates Osteoclast Differentiation and Survival by Mediating the NFATc1, AKT, and MEK/ERK Signaling PathwaysPLOS ONE, 2011
- Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone lossGene Therapy, 2010
- MKP-1 Is Necessary for T Cell Activation and FunctionJournal of Biological Chemistry, 2009
- MAP Kinase Phosphatase-1 Protects against Inflammatory Bone LossJournal of Dental Research, 2009
- Role of MKP-1 in Osteoclasts and Bone HomeostasisThe American Journal of Pathology, 2009
- Osteoimmunology: Interactions of the Bone and Immune SystemEndocrine Reviews, 2008
- Receptor Activator of Nuclear Factor-κB Ligand-Induced Nuclear Factor of Activated T Cells (C1) Autoregulates Its Own Expression in Osteoclasts and Mediates the Up-Regulation of Tartrate-Resistant Acid PhosphataseMolecular Endocrinology, 2008
- NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP)Molecular Endocrinology, 2008